Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
24.5 USD | -2.06% | -3.39% | +28.00% |
05-13 | Piper Sandler Adjusts Price Target on Myriad Genetics to $28 From $23, Maintains Neutral Rating | MT |
05-08 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.00% | 2.26B | |
-6.26% | 12.23B | |
-3.93% | 8.17B | |
+7.10% | 5.78B | |
+31.06% | 5.74B | |
-7.47% | 4.24B | |
-56.75% | 2.97B | |
+12.56% | 2.73B | |
-4.67% | 2.38B | |
-4.21% | 1.87B |
- Stock Market
- Equities
- MYGN Stock
- News Myriad Genetics, Inc.
- SVB Securities Adjusts Price Target on Myriad Genetics to $25 From $27, Maintains Market Perform Rating